Stool inflammation marker in intestinal parasite infections
Part of Digestive system, Infections clinical trials.
This study looks at a stool marker called fecal calprotectin, which can show inflammation in the gut, in people infected with certain intestinal parasites. It aims to see if these parasites cause inflammation, which could help doctors understand and treat related symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be one of three groups: (1) have GI symptoms and be infected with Blastocystis hominis or Entamoeba histolytica, (2) have GI symptoms but no intestinal parasites, or (3) be a healthy volunteer without GI symptoms or parasites.
- You must not have taken antiparasitic drugs or antibiotics in the last 2 weeks.
- You must not have infections with more than one type of intestinal parasite.
- You must not have any intestinal parasites other than Blastocystis hominis or Entamoeba histolytica.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if a stool test (fecal calprotectin) can help doctors tell apart different causes of long-term stomach and bowel symptoms in children. It might help avoid unnecessary invasive tests like endoscopy.
This trial tests a new stool test to measure calprotectin levels, which could help doctors tell the difference between inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). If you have symptoms like stomach pain, diarrhea, or weight loss and are about to have a colonoscopy, you may be able to join.
This study looks at stool samples to see if certain markers can quickly tell whether a biologic medicine is starting to work for moderate-to-severe ulcerative colitis. If successful, this could help doctors make faster, smarter treatment decisions.
This study tests non-invasive tools to find active inflammation in people with Crohn's disease or ulcerative colitis. You may need to give extra stool samples before your colonoscopy and calprotectin test.
This study looks at whether a simple stool test can tell if treatment is healing the gut lining in people with moderate to severe ulcerative colitis who are starting their first biologic medicine. If it works, this test might help doctors adjust treatment earlier.
This study checks if a simple stool test (fecal calprotectin) can help predict the presence of enlarged veins in the esophagus (varices) in people with cirrhosis. If successful, this could offer a non-invasive way to screen for this serious complication.
Hear when a new Fecal Calprotectin in Intestinal Protozoa trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.